The 2016 revised World Health Organization definition of ‘myelodysplastic syndrome with isolated del(5q)’; prognostic implications of single versus double cytogenetic abnormalities-Reference-Cited by-同舟云学术

The 2016 revised World Health Organization definition of ‘myelodysplastic syndrome with isolated del(5q)’; prognostic implications of single versus double cytogenetic abnormalities

Published:2017-04-17 Issue:1 Volume:178 Page:57-60
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gurney Mark¹^ORCID,Patnaik Mrinal M.²,Hanson Curtis A.³,Litzow Mark R.²,Al-Kali Aref²,Ketterling Rhett P.⁴,Tefferi Ayalew²,Gangat Naseema²

Affiliation:

1. Department of Internal Medicine; Mayo Clinic; Rochester MN USA

2. Division of Hematology; Mayo Clinic; Rochester MN USA

3. Division of Hematopathology; Mayo Clinic; Rochester MN USA

4. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14636/fullpdf

Reference10 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study;Germing;Leukemia,2012

3. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes;Greenberg;Blood,2012

4. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion;List;The New England Journal of Medicine,2006

5. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q;Mallo;Leukemia,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic syndromes;Rodak's Hematology;2020

2. Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion;International Journal of Molecular Sciences;2018-10-21

3. Current therapy and new drugs: a road to personalized treatment of myelodysplastic syndromes;Expert Review of Precision Medicine and Drug Development;2017-12-27